GL1X · GenesisL1 explorer

MolNFT v1 · #154524 · protein

Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor

6KDX · Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase…: “Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor”. X-ray diffraction, 3 ligands (D6X, ZN, MG), 7 pockets (best druggability 0.75). MolNFT v1…

PDB
6KDX
Type
protein
Length
648 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17, 3.1.4.35
UniProt
Q9Y233
Ligands
D6X, ZN, MG
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35)protein32472% helix, 0% strandQ9Y233

Ligands and binding sites

  • D6X · N-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]quinolin-2-amine · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16740.750.8164MG, D6X
27310.720.7856empty
34510.720.8250MG
4520.610.9321empty
51080.400.7617empty

Interfaces

1 interface between chains.

  • A–B · 893 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 6KDX · Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.